Navigate insurance coverage for GLP-1 weight loss medications like Wegovy and Zepbound by learning about costs, eligibility requirements, prior authorizations, and appeals to maximize your chances of ...

Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...

While the new anti-obesity medications known as GLP-1s are only one tool to combat obesity and cardiometabolic disease, they have changed the medical landscape and are clinically important in treating ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of ...

Even higher use seen in patients without type 2 diabetes. (HealthDay News) — The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing ...

If you've been denied access to a GLP-1 medication for weight loss, you are not alone. However, there are new science-backed options you should know about that don't require a prescription. Health ...

Hidden homeowner costs climb to nearly $16,000 a year, Eli Lilly approaches trillion-dollar status amid weight-loss drug ...

The clock is ticking: In two weeks, millions of Americans could lose access to the affordable medication that’s helping them lose weight and improve their health. I should know — I’m one of them. In ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

10 most-read opioid stories in 2020 Many public health experts have said the pandemic has exacerbated the opioid epidemic, as social isolation, moving recovery programs to remote settings and stress ...